SYLVESTER, Richard

Email Alert RSS Feed

Profile

Full Name
SYLVESTER, Richard
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [1991 TO 1999]

Results 1-20 of 24 (Search time: 0.003 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
11999Orchiectomy and orchiectomy plus mitomycin C for metastatic prostate cancer in patients with poor prognosis: r=the final results of a European organization for research in cancer therapy genitourinary group trialde Reijke, T.M.; Keuppens, F.I.; Whelan, P.; Kliment, J.; Robinson, M.R.G.; Rea, L.A.; SYLVESTER, RichardJournal Contribution
21999Impact of the treating institution on survival of patients with "poor progosis" metastatic nonseminomaCollette, L.; SYLVESTER, Richard; Stenning, S.P.; Fossa, S.D.; Mead, G.M.; de Wit, R.; de Mulder, P.H.M.; Neymark, N.; Lallemand, E.; Kaye, S.B.Journal Contribution
31998Serum alpha-fetoprotein surge after the iniation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceSYLVESTER, Richard; de Wit, R.; Collette, L.; de Mulder, P.H.M.; Sleijfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G.Journal Contribution
41998Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a randomized Medical Research Council/European Organization for Research and Treatment of Cancer studyKaye, S.B.; Mead, G.M.; Fossa, S.; Cullen, M.; de Wit, R.; Bodrogi, I.; van Groeningen, C.; SYLVESTER, Richard; Collette, L.; Stenning, S.; de Prijck, L.; Lallemand, E.Journal Contribution
51998Four cycles of BEP vs four cycles of VIR in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Groupde Wit, R.; Stoter, G.; Sleijfer, D.T.H.; Neijt, J.P.; ten Bokkel Huinink, W.W.; de Prijck, L.; Collette, L.; SYLVESTER, RichardJournal Contribution
61998Identifying the types of missingness in quality of life data from clinical trialsCurran, Desmond; Bacchi, M.; Hsu Schmitz, Shu-Fang; MOLENBERGHS, Geert; SYLVESTER, RichardJournal Contribution
71997An introduction to the statistical design of phase III cancer clinical trialsSYLVESTER, RichardJournal Contribution
81997Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection aloneKurth, K.; Tunn, U.; Ay, R.; Schroder, F.; Pavone-Macaluso, M.; Debruyne, F.; ten Kate, F.; de Pauw, M.; SYLVESTER, RichardJournal Contribution
91997Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European organization for research and treatment of cancer randomized phase III trialBartelink, H.; Rubens, R.D.; van der Schueren, E.; SYLVESTER, RichardJournal Contribution
101997Analysis and presentationFriberg, S.; Taube, A.; SYLVESTER, Richard; Oesterling, J.E.Journal Contribution
111997Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a multi-institutional Medical Research Council/ European Organization for Research and Treatment of Cancer TrialHorwich, A.; Sleijfer, D.T.; Fossa, S.D.; Kaye, S.B.; Oliver, R.T.D.; Cullen, M.H.; Mead, G.M.; de Wit, R.; de Mulder, P.H.M.; Dearnaley, D.P.; Cook, P.A.; Stenning, S.P.; SYLVESTER, RichardJournal Contribution
121997Does isoniazed reduce side effects of intravesical Bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of EORTC protocol 30911Vegt, P.; van der Meijden, A.; SYLVESTER, Richard; Brausi, M.; Holtl, W.; de Balincourt, C.Journal Contribution
131997Importance of bleomycin in combination chemotherapy for good prognosis testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Groupde Wit, R.; Stoter, G.; Kaye, S.B.; Steijffer, D.Th.; Jones, W.G.; ten Bokkel Huinink, W.W.; Rea, L.A.; Collette, L.; SYLVESTER, RichardJournal Contribution
141997Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminatomous testicular cancerde Wit, R.; SYLVESTER, Richard; Tsitsa, C.; de Mulder, P.H.M.; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G.Journal Contribution
151996Marker tumour response to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumoursvan der Meijden, A.P.M.; Hall, R.R.; Pavone Macaluso, M.; Pawinski, R.; SYLVESTER, Richard; van Glabbeke, M.Journal Contribution
161996Phase II trails in Ta, T1 bladder cancer: the marker tumour conceptvan der Meijden, A.P.M.; Hall, R.R.; Kurth, K.H.; Bouffioux, Ch.; SYLVESTER, RichardJournal Contribution
171996Prognostic factors in metastatic prostate cancerSYLVESTER, RichardJournal Contribution
181996A combined analysis of European Organization for Research and Treatment of Cancer and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancerPawinski, R.; SYLVESTER, Richard; Kurth, K.; Bouffioux, Christophe; van der Meijden, A.; Parmar, M.; BIJNENS, LucJournal Contribution
191996The role of biostatistics in cancer researchSYLVESTER, RichardJournal Contribution
201996Can the forest plot be simplified without loosing relevant information in meta-analyses?BIJNENS, Luc; SYLVESTER, Richard; Collette, L.; Ivanov, A.; Hoctin, Boes G.Journal Contribution
show all